CA
NZ
UK
AU
IND
US
● No company-specific announcement was found for ImmunityBio, and the advance reflects speculative biotech and momentum trading.
● A review of reporting surfaced no clinical update,Earningsrelease, regulatory development, financing,Partnershipor analyst action behind the decline.
● No clinical readout, regulatory update, financing disclosure or corporate announcement tied to the session could be confirmed.
● No clinical-trial result, regulatory decision, financing,Partnershipor analyst action could be tied to the session.
● Cardiol Therapeutics closed at $1.41 on Friday, October 2, 2026, a decline of 9.62% on the session.
● No company-specific announcement was found for Claritev, and the advance reflects general market momentum in a strong, broad-based rally.
● Eupraxia Pharmaceuticals closed at $7.24 on Friday, October 2, 2026, a decline of 7.54% on the session.
● No clinical readout, regulatory update, financing disclosure or corporate announcement tied to the session could be confirmed.
● Foghorn Therapeutics closed at $2.02 on Friday, October 2, 2026, a decline of 30.82% on the session.
● NoEarningsrelease,Businessupdate, corporate announcement or analyst action could be linked to the session.
Please wait processing your request...